Journal Mobile Options
Table of Contents
Vol. 215, No. 1, 2007
Issue release date: June 2007
Add to my selection Citation Download
Dermatology 2007;215:84–85
(DOI:10.1159/000102044)
Letters to Dermatology

Etanercept in the Treatment of Vitiligo

Rigopoulos D.a · Gregoriou S.a · Larios G.a · Moustou E.a · Belayeva-Karatza E.a · Kalogeromitros D.b
aDepartment of Dermatology, Andreas Sygros Hospital, and bAttikon Hospital, University of Athens Medical School, Athens, Greece Dermatology 2007;215:84–85 (DOI:10.1159/000102044)

First-Page Preview
Abstract of Letters to Dermatology

 goto top of outline Author Contacts

Rigopoulos Dimitris
Department of Dermatology
Andreas Sygros University Hospital
5 Ionos Dragoumi Street, GR–16121 Athens (Greece)
Tel. +30 210 724 0632, Fax +30 210 721 1122, E-Mail drigop@hol.gr


 goto top of outline Article Information

Number of Print Pages : 2


 goto top of outline Publication Details

Dermatology

Vol. 215, No. 1, Year 2007 (Cover Date: June 2007)

Journal Editor: Saurat, J.-H. (Geneva)
ISSN: 1018–8665 (print), 1421–9832 (Online)

For additional information: http://www.karger.com/DRM


Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.